The use of β(2)-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines

Despite scientific evidence proving that inhaled β(2)-adrenergic receptor (β(2)-AR) agonists can reverse bronchoconstriction in all ages, current guidelines advocate against the use of β(2)-AR bronchodilators in infants with viral bronchiolitis because clinical trials have not demonstrated an overal...

Descripción completa

Detalles Bibliográficos
Autores principales: Nino, Gustavo, Rodríguez-Martínez, Carlos E., Castro-Rodriguez, Jose A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553108/
https://www.ncbi.nlm.nih.gov/pubmed/33083437
http://dx.doi.org/10.1183/23120541.00135-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553108/
https://www.ncbi.nlm.nih.gov/pubmed/33083437
http://dx.doi.org/10.1183/23120541.00135-2020

Ejemplares similares